German Parliament Debates Prenatal Tests - Motion Calls for Broader Data Basis - German Lawmakers Demand Stricter Rules for Prenatal Genetic Testing

Over 100 German lawmakers have pushed for tighter controls on non-invasive prenatal tests (NIPT). The proposed motion seeks clearer rules on how these genetic blood tests are used and funded by public health insurance. Concerns centre on rising test rates, false positives, and ethical implications since their introduction in 2022.

Estimates suggest that between 20% and 30% of pregnant women in Germany—roughly 150,000 to 200,000 each year—have undergone NIPT since 2022. The figures come from health insurance data and studies up to 2025, though exact numbers remain unpublished. Despite the availability of NIPT, the number of invasive prenatal procedures has not declined.

Lawmakers highlighted the emotional strain caused by false-positive results, which can lead to unnecessary anxiety for expectant parents. SPD representative Dagmar Schmidt stressed the importance of better-informed choices, arguing that women need clearer guidance before opting for testing.

The motion proposes two key measures: a monitoring system to track NIPT usage and outcomes, and an expert panel to evaluate the legal, ethical, and health policy consequences of insurance coverage. CSU lawmaker Emmi Zeulner stated the goal was to foster transparency and responsible use of prenatal testing.

Not all politicians backed the motion. Some argued that stricter rules could infringe on women's right to make their own decisions about prenatal care. The debate also focused on preventing NIPT from becoming a routine test for conditions like Down syndrome.

The proposed changes aim to balance access to testing with stronger oversight. If approved, the monitoring system and expert panel would provide clearer data on NIPT's impact. The outcome could shape future policies on prenatal genetic screening in Germany.